Revvity Inc (RVTY)
112.54
+1.43
(+1.29%)
USD |
NYSE |
Nov 22, 15:52
Revvity Total Assets (Quarterly): 12.77B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 12.77B |
June 30, 2024 | 13.42B |
March 31, 2024 | 13.43B |
December 31, 2023 | 13.56B |
September 30, 2023 | 13.42B |
June 30, 2023 | 14.22B |
March 31, 2023 | 14.64B |
December 31, 2022 | 14.13B |
September 30, 2022 | 13.82B |
June 30, 2022 | 14.19B |
March 31, 2022 | 14.85B |
December 31, 2021 | 15.00B |
September 30, 2021 | 14.90B |
June 30, 2021 | 8.739B |
March 31, 2021 | 8.763B |
December 31, 2020 | 7.960B |
September 30, 2020 | 6.866B |
June 30, 2020 | 6.637B |
March 31, 2020 | 6.384B |
December 31, 2019 | 6.539B |
September 30, 2019 | 6.489B |
June 30, 2019 | 6.399B |
March 31, 2019 | 6.086B |
December 31, 2018 | 5.976B |
September 30, 2018 | 5.862B |
Date | Value |
---|---|
June 30, 2018 | 5.958B |
March 31, 2018 | 6.126B |
December 31, 2017 | 6.091B |
September 30, 2017 | 4.739B |
June 30, 2017 | 4.605B |
March 31, 2017 | 4.341B |
December 31, 2016 | 4.277B |
September 30, 2016 | 4.305B |
June 30, 2016 | 4.194B |
March 31, 2016 | 4.211B |
December 31, 2015 | 4.166B |
September 30, 2015 | 4.032B |
June 30, 2015 | 4.083B |
March 31, 2015 | 4.028B |
December 31, 2014 | 4.128B |
September 30, 2014 | 3.886B |
June 30, 2014 | 3.937B |
March 31, 2014 | 3.971B |
December 31, 2013 | 3.947B |
September 30, 2013 | 3.852B |
June 30, 2013 | 3.811B |
March 31, 2013 | 3.808B |
December 31, 2012 | 3.902B |
September 30, 2012 | 3.890B |
June 30, 2012 | 3.801B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.384B
Minimum
Mar 2020
15.00B
Maximum
Dec 2021
11.71B
Average
13.43B
Median
Total Assets (Quarterly) Benchmarks
Bionano Genomics Inc | 87.36M |
Bruker Corp | 6.113B |
Azenta Inc | 2.100B |
Harvard Bioscience Inc | 131.24M |
Akoya Biosciences Inc | 129.97M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 4.848B |
Shareholders Equity (Quarterly) | 7.922B |
Debt to Equity Ratio | 0.4023 |
Current Ratio | 3.559 |
Net Debt Paydown Yield | 1.51% |